[Influenza vaccination of children with hemophilia].
51 haemophilic children aged from 7 to 16 years was vaccinated against influenza in Paediatric Department of Haematology and Oncology in November and December of 1993. Each dose of subunit vaccine manufactured by Wyeth-USA, contained 15 micrograms of each haemagglutinin strains as recommended for the season. The antibody level was studied before and after influenza vaccination in vaccinated and control group as well. 5-time rise of geometric mean antibody titre was found for H1N1 and H3N2 antigens after vaccination of the children group. Slightly lower, 2.7-time rise of GMT was showed for HB haemagglutinin of influenza virus. There was no significant rise of GMT for any among three studied virus haemagglutinin.
Klukowska
A
A
Katedry i Kliniki Pediatrii, Hematologii i Onkologii A.M. w Warszawie.
Brydak
L
L
Rokicka-Milewska
R
R
Gosk
B
B
Wielopolska
M
M
Adamowicz-Salach
A
A
Rudnicka
H
H
Regnery
H
H
Cox
N
N
D000293:Adolescent; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D006387:Hemagglutination, Viral; D006467:Hemophilia A / Q000276:immunology*; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control
D000914:Antibodies, Viral; D007252:Influenza Vaccines
Szczepienia przeciw grypie dzieci chorych na hemofilie.